Shephard Mpofu's most recent trade in Acelyrin Inc was a trade of 3,211 Common Stock done at an average price of $2.7 . Disclosure was reported to the exchange on March 17, 2025.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Acelyrin Inc | Shephard Mpofu | Chief Medical Officer | Sale of securities on an exchange or to another person at price $ 2.74 per share. | 17 Mar 2025 | 3,211 | 121,789 | - | 2.7 | 8,811 | Common Stock |
| Acelyrin Inc | Shephard Mpofu | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 Jan 2025 | 125,000 | 125,000 | - | 0 | Common Stock | |
| Acelyrin Inc | Shephard Mpofu | Chief Medical Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 23 May 2024 | 328,860 | 328,860 | - | - | Employee Stock Option (right to buy) |